SALT LAKE CITY, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine, will hold its fourth quarter and full year ...

Myriad Genetics reported an earnings-per-share loss of $0.43 in the third quarter. The company said its testing volumes were up. Myriad’s shares hit a 52-week low on Thursday. The stock hit its ...

Throughout the years, medical advancements have shown that genetic testing can significantly reduce the risk of developing certain cancers. Genetic testing examines changes in a person’s DNA sequence ...

North America dominated the genetic testing market in 2024. Asia Pacific is expected to grow at the fastest CAGR in the market during the forecast period. By technology, the next-generation sequencing ...

Honoring one of the most influential breeders in cannabis history, this release celebrates the global impact of DNA Genetics’ 24K Gold. DNA Genetics crafted 24K (also known as Kosher Tangie) by ...

This article was published 24/06/2013 (4430 days ago), so information in it may no longer be current. Prenatal genetic screening shows the medical future of offspring. New non-invasive prenatal ...

Please provide your email address to receive an email when new articles are posted on . This study included 24 genetic variants related to eczema and 18 environmental factors. Children without ...

In recent years, Canadian police have looked to genetic genealogy to help solve cold cases dating back decades. The technique is relatively new and is continuing to make headlines — including this ...